Updates on GLP-1 Agonists and Eli Lilly's Retatrutide Developments | Retatrutide News

Recent updates on GLP-1 agonists, including Retatrutide, highlight ongoing research in obesity treatment. Eli Lilly is advancing its metabolic pipeline,...
Market News · October 19, 2026